JESSICA MILLER: Open Payments
NPI 1174019798 · DEXTER, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$971 in 51 payments from 9 companies in 2025. Trend: 2023 $700 · 2024 $785 · 2025 $971
Food & beverage: $871Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $337 |
| ABBVIE INC. | 23 | $294 |
| Regeneron Healthcare Solutions, Inc. | 1 | $149 |
| Novartis Pharmaceuticals Corporation | 5 | $102 |
| Lilly USA, LLC | 1 | $22 |
| Organon LLC | 2 | $17 |
| LEO Pharma Inc. | 1 | $17 |
| Galderma Laboratories, L.P. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, RINVOQ, COSENTYX, TALTZ, Rhapsido, ADBRY.
Industry payments across MO — which companies pay providers there.
